In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. / Hasselstøm, Jørgen; Linnet, Kristian.

I: Drug Metabolism and Drug Interactions, Bind 21, Nr. 3-4, 06.07.2006, s. 187-211.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hasselstøm, J & Linnet, K 2006, 'In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions', Drug Metabolism and Drug Interactions, bind 21, nr. 3-4, s. 187-211.

APA

Hasselstøm, J., & Linnet, K. (2006). In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. Drug Metabolism and Drug Interactions, 21(3-4), 187-211.

Vancouver

Hasselstøm J, Linnet K. In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. Drug Metabolism and Drug Interactions. 2006 jul. 6;21(3-4):187-211.

Author

Hasselstøm, Jørgen ; Linnet, Kristian. / In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. I: Drug Metabolism and Drug Interactions. 2006 ; Bind 21, Nr. 3-4. s. 187-211.

Bibtex

@article{87ca206a4a3b417b9459337f036d9814,
title = "In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions",
abstract = "The metabolism of the atypical antipsychotic quetiapine was investigated by in vitro methods. Pharmacokinetic parameters were determined in human liver microsomes and recombinant cytochrome P450 measuring substrate depletion and product formation. The cytochrome P450 isozymes CYP3A4 and CYP2D6 displayed activity towards quetiapine. The isozyme CYP2D6 played a minor role in the metabolism of quetiapine as CYP3A4 contributed 89% to the overall metabolism. A Km value of 18 μM was determined by substrate depletion, suggesting linear kinetics under therapeutic conditions. Drugs known to inhibit CYP3A4, such as ketoconazole and nefazodone, displayed almost complete inhibition at low concentrations, whereas inhibitors of CYP2D6 do not seem to have a clinically relevant effect.",
keywords = "Drug-drug interactions, Metabolism, Quetiapine, Substrate depletion",
author = "J{\o}rgen Hasselst{\o}m and Kristian Linnet",
year = "2006",
month = jul,
day = "6",
language = "English",
volume = "21",
pages = "187--211",
journal = "Drug Metabolism and Drug Interactions",
issn = "2363-8907",
publisher = "De Gruyter",
number = "3-4",

}

RIS

TY - JOUR

T1 - In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions

AU - Hasselstøm, Jørgen

AU - Linnet, Kristian

PY - 2006/7/6

Y1 - 2006/7/6

N2 - The metabolism of the atypical antipsychotic quetiapine was investigated by in vitro methods. Pharmacokinetic parameters were determined in human liver microsomes and recombinant cytochrome P450 measuring substrate depletion and product formation. The cytochrome P450 isozymes CYP3A4 and CYP2D6 displayed activity towards quetiapine. The isozyme CYP2D6 played a minor role in the metabolism of quetiapine as CYP3A4 contributed 89% to the overall metabolism. A Km value of 18 μM was determined by substrate depletion, suggesting linear kinetics under therapeutic conditions. Drugs known to inhibit CYP3A4, such as ketoconazole and nefazodone, displayed almost complete inhibition at low concentrations, whereas inhibitors of CYP2D6 do not seem to have a clinically relevant effect.

AB - The metabolism of the atypical antipsychotic quetiapine was investigated by in vitro methods. Pharmacokinetic parameters were determined in human liver microsomes and recombinant cytochrome P450 measuring substrate depletion and product formation. The cytochrome P450 isozymes CYP3A4 and CYP2D6 displayed activity towards quetiapine. The isozyme CYP2D6 played a minor role in the metabolism of quetiapine as CYP3A4 contributed 89% to the overall metabolism. A Km value of 18 μM was determined by substrate depletion, suggesting linear kinetics under therapeutic conditions. Drugs known to inhibit CYP3A4, such as ketoconazole and nefazodone, displayed almost complete inhibition at low concentrations, whereas inhibitors of CYP2D6 do not seem to have a clinically relevant effect.

KW - Drug-drug interactions

KW - Metabolism

KW - Quetiapine

KW - Substrate depletion

UR - http://www.scopus.com/inward/record.url?scp=33745668220&partnerID=8YFLogxK

M3 - Journal article

C2 - 16841513

AN - SCOPUS:33745668220

VL - 21

SP - 187

EP - 211

JO - Drug Metabolism and Drug Interactions

JF - Drug Metabolism and Drug Interactions

SN - 2363-8907

IS - 3-4

ER -

ID: 230033026